Losartan Potassium Prices December 2023
Product
|
Category |
Region |
Price |
Losartan Potassium |
Pharma API |
China |
75015 USD/MT |
The price of losartan potassium in China reached 75015 USD/MT during the Q4 2023. The market experienced limited supplies, leading to an increase in prices. Additionally, there was a surge in consumer demand during the festive season, further driving up the prices. Besides, the escalation of crude oil prices due to extended oil production cuts by OPEC+ countries and the Israel-Hamas conflict resulted in higher business expenses and output costs, contributing to the rise in prices. China also experienced an increase in new orders and sales, surpassing the current supply levels. The Chinese manufacturing activities rebounded in November, displaying the swiftest expansion in the last three months.
Losartan Potassium Price Trend, Market Analysis, and News
IMARC’s newly published report, titled “Losartan Potassium Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data,” offers an in-depth analysis of losartan potassium pricing, covering an analysis of global and regional market trends and the critical factors driving these price movements.
It encompasses an in-depth review of spot price of losartan potassium at major ports, a breakdown of prices including Ex Works, FOB, and CIF, alongside a region-wise dissection of losartan potassium price trend across North America, Europe, Asia Pacific, Latin America, the Middle East and Africa.
The report examines the elements influencing losartan potassium price fluctuations, such as changes in raw material costs, supply-demand dynamics, geopolitical factors, and industry-specific developments. Additionally, it integrates the latest market news, providing stakeholders with up-to-date information on market shifts, regulatory changes, and technological advancements, thereby offering a comprehensive overview that aids in strategic decision-making and forecasting.
![Losartan Potassium Price Trend](https://www.imarcgroup.com/CKEditor/c36a4297-69b7-443f-9cbf-09f4685b9d26pricing-reports.webp)
Losartan Potassium Market Analysis
The global losartan potassium market size reached 23.8 Thousand Tonnes in 2023. By 2032, IMARC Group expects the market to reach 35.4 Thousand Tonnes, at a projected CAGR of 4.50% during 2023-2032.
- The market is primarily driven by the increasing prevalence of hypertension. Hypertension is a condition when the pressure in blood vessels is too high (140/90 mmHg or higher). According to the WORLD HEALTH ORGANIZATION, an estimated 1.28 billion adults aged 30–79 years worldwide have hypertension. Besides, less than half of adults (42%) with hypertension are diagnosed and treated. Losartan potassium is widely used to treat hypertension. Consequently, the rising prevalence of hypertension, driven by aging populations, increasing obesity rates, and lifestyle factors such as poor diet and lack of physical activity, significantly contributes to the demand for losartan potassium.
- Losartan potassium has also become more accessible due to its cost-effectiveness, and the expiry of its patent. In recent years, generic versions have entered the market, significantly reducing costs and making the medication available to a broader segment of the population. This, coupled with the rising healthcare expenditure across the globe is also influencing the market growth. According to the CENTERS FOR MEDICARE & MEDICAID SERVICES, U.S. health care spending grew 4.1% to reach $4.5 trillion in 2022, faster than the increase of 3.2% in 2021. Besides, spending on physician and clinical services increased 2.7% to $8,84.9 billion in 2022, whereas retail prescription drug spending increased 8.4% to $405.9 billion in 2022, a faster rate than in 2021.
- At present, governments of various countries are focusing on reducing the risk of cardiovascular diseases through preventive care due to the growing prevalence of these diseases, which includes the management of hypertension. Hypertension is the leading preventable risk factor for cardiovascular disease (CVD) and all-cause mortality worldwide. According to CENTERS FOR DISEASE CONTROL and PREVENTION, About 695,000 people in the United States died from heart disease in 2021 which is 1 in every 5 deaths. Besides, every year, about 805,000 people in the United States have a heart attack. Losartan potassium is a common drug of choice in treatment protocols and preventive strategies against heart disease, which is driving its market growth.
Losartan Potassium News
The report covers the latest developments, updates, and trends impacting the global losartan potassium market, providing stakeholders with timely and relevant information. This segment covers a wide array of news items, including the inauguration of new production facilities, advancements in losartan potassium production technologies, strategic market expansions by key industry players, and significant mergers and acquisitions that impact the losartan potassium price trend.
Latest developments in the losartan potassium industry:
- In 2023, Granules India received approval from the US Food & Drug Administration (USFDA) to market losartan potassium tablets in strengths of 25 mg, 50 mg, and 100 mg.
Product Description
Losartan potassium is a medication commonly used to manage hypertension and to help protect the kidneys from damage due to diabetes. It is also prescribed to treat heart failure and lower the risk of strokes in patients with an enlarged heart and high blood pressure. Losartan belongs to a class of drugs known as angiotensin II receptor blockers (ARBs), which work by blocking the action of angiotensin II, a chemical in the body that causes blood vessels to tighten and narrow.
Losartan potassium is also known for its renal protective properties, particularly in patients with type 2 diabetes. It can help to reduce the progression of diabetic nephropathy, which is a type of kidney disease that is a common complication of diabetes. Losartan potassium is taken orally, typically once per day, and is available under various brand names and generic medication.
Regional Coverage
The report provides a detailed analysis of the losartan potassium market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of ex-works, FOB, and CIF prices, as well as the key factors influencing the losartan potassium price trend.
Global Losartan potassium Price
The report offers a holistic view of the global losartan potassium pricing trends in the form of losartan potassium price charts, reflecting the worldwide interplay of supply-demand balances, international trade policies, and overarching economic factors that shape the market on a macro level. This comprehensive analysis not only highlights current price of losartan potassium but also provides insights into historical price trends, enabling stakeholders to understand past fluctuations and their underlying causes.
The report also delves into price forecast models, projecting future price movements based on a variety of indicators such as expected changes in supply chain dynamics, anticipated policy shifts, and emerging market trends. By examining these factors, the report equips industry participants with the necessary tools to make informed strategic decisions, manage risks, and capitalize on market opportunities. Furthermore, it includes a detailed losartan potassium demand analysis, breaking down regional variations and identifying key drivers specific to each geographic market, thus offering a nuanced understanding of the global pricing landscape.
Europe Losartan potassium Price
In the concluding quarter of 2023, the European losartan potassium market experienced fluctuating pricing dynamics influenced by an uptick in prices, driven by increased demand from the food and healthcare sectors, higher consumer spending, and reduced market inventories. A positive shift in business sentiment in Germany, alleviating factors hindering economic growth, contributed to this price surge. Furthermore, declining business sentiments in Europe, especially in Germany, contributed to an overall reduction in losartan potassium demand.
This analysis can be extended to include detailed losartan potassium price information for a comprehensive list of countries.
Region |
Countries Covered |
Europe |
Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal, and Greece, among other European countries. |
North America Losartan potassium Price
The fourth quarter of 2023 brought notable developments to the North American losartan potassium market, especially in the United States. Initially, prices experienced a significant increase from October to November due to heightened consumer spending, signs of easing inflation, and more affordable gas prices. However, a decline occurred in December, attributed to reduced demand from downstream industries and an ample supply in the market. Moreover, there was heightened consumer confidence and sustained high demand due to decreased inflationary pressures, resulting in increased consumer spending.
Specific losartan potassium historical data within the United States and Canada can also be provided.
Region |
Countries Covered |
North America |
United States and Canada |
Middle East and Africa Losartan potassium Price
The report explores the losartan potassium pricing trends in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.
In addition to region-wise data, information on losartan potassium prices for countries can also be provided.
Region |
Countries Covered |
Middle East & Africa |
Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco, among other Middle Eastern and African countries. |
Asia Pacific Losartan potassium Price
In the Asia Pacific region, the pricing of losartan potassium was influenced by limited supplies, leading to an increase in prices. Additionally, there was a surge in consumer demand during the festive season, further driving up the prices of losartan potassium. Furthermore, the escalation of crude oil prices due to extended oil production cuts by OPEC+ countries and the Israel-Hamas conflict resulted in higher business expenses and output costs, contributing to the rise in prices. Among the countries in the region, China saw significant changes in the price of Losartan Potassium. The market experienced an increase in new orders and sales, surpassing the current supply levels.
This losartan potassium price analysis can be expanded to include a comprehensive list of countries within the region.
Region |
Countries Covered |
Asia Pacific |
China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand, among other Asian countries. |
Latin America Losartan potassium Price
The analysis of losartan potassium prices in Latin America provides a detailed overview, reflecting the unique market dynamics in the region influenced by economic policies, industrial growth, and trade frameworks.
This comprehensive review can be extended to include specific countries within the region.
Region |
Countries Covered |
Latin America |
Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru, among other Latin American countries. |
Report Coverage
Key Attributes |
Details |
Product Name |
Losartan Potassium |
Report Features |
Exploration of Historical Trends and Market Outlook, Industry Demand, Industry Supply, Gap Analysis, Challenges, Losartan Potassium Price Analysis, and Segment-Wise Assessment. |
Currency/Units |
US$ (Data can also be provided in local currency) or Metric Tons |
Region/Countries Covered |
The current coverage includes analysis at the global and regional levels only.
Based on your requirements, we can also customize the report and provide specific information for the following countries:
Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand*
Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece*
North America: United States and Canada
Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru*
Middle East & Africa: Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco*
*The list of countries presented is not exhaustive. Information on additional countries can be provided if required by the client. |
Information Covered for Key Suppliers |
- Company Overview
- Business Description
- Product Portfolio
- Recent Trends and Developments
|
Customization Scope |
The report can be customized as per the requirements of the customer |
Report Price and Purchase Option |
Plan A: Monthly Updates - Annual Subscription
- Scope
- Historical Data for the Current Month
- Forecast for Next Month
- Total Deliverables Per Year: 12 (One Per Month)
- Includes: One PDF and Excel datasheet per month, Post Purchase Analyst Support throughout the year
Plan B: Quarterly Updates - Annual Subscription
- Scope
- Historical Data for the Current Quarter
- Forecast for Next Quarter
- Total Deliverables Per Year: 4 (One Per Quarter)
- Includes: One PDF and Excel datasheet per Quarter, Post Purchase Analyst Support throughout the year
Plan C: Biannually Updates - Annual Subscription
- Scope
- Historical Data for the Current Half
- Forecast for the Next Half
- Total Deliverables Per Year: 2 (One Per 6 Months)
- Includes: One PDF and Excel datasheet per Half, Post Purchase Analyst Support throughout the year
|
Post-Sale Analyst Support |
360-degree analyst support after report delivery |
Delivery Format |
PDF and Excel through email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Benefits for Stakeholders:
- IMARC’s report presents a detailed analysis of losartan potassium pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
- The study examines factors affecting losartan potassium price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
- The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
- IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The losartan potassium price charts ensure our clients remain at the forefront of the industry.